{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:36:52Z","timestamp":1794670612424,"version":"4.9.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Although alternative donors extend transplant access, whether recipient ancestry affects the time to allogeneic transplant is not established. We analyzed the likelihood of clinically significant delays to allograft by patient ancestry in 313 adult patients with acute myelogenous leukemia (AML) who underwent transplantation. Non-European ancestry patients (n\u00a0= 99) were more likely than Europeans (n\u00a0= 214) to receive HLA-mismatched donor allografts (45% vs 24%). Overall, the median time from transplant indication to allograft was 127 days (range, 57-1683). In multivariable analysis, non-Europeans had an increased risk of prolonged indication to transplant time &amp;gt;180 days owing to significant delays in indication to consult &amp;gt;90 days and consult to transplant &amp;gt;120 days. Compared with recipients of HLA-matched unrelated donors (URDs), HLA-mismatched adult donor recipients were at an increased risk of delayed indication to transplant, whereas HLA-identical sibling and cord blood recipients were at a lower risk. Subanalysis showed more indication to transplant delays &amp;gt;180 days in non-European (44%) vs European (19%) 8\/8 URD recipients. Finally, the pandemic further exacerbated delays for non-Europeans. In summary, although non-European patients with AML are less likely to receive 8\/8 URDs as expected, if they do, their transplants are delayed. HLA-identical siblings and cord blood facilitate the fastest transplants regardless of patient ancestry, whereas other adult donor transplants are delayed. Strategies to mitigate referral barriers, hasten donor evaluation, and use all alternative donor sources are critical to ensure timely transplantation for patients with AML.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2022008572","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T19:57:01Z","timestamp":1665777421000},"page":"3824-3833","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-1583","authenticated-orcid":false,"given":"Warren B.","family":"Fingrut","sequence":"first","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boglarka","family":"Gyurkocza","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-6684","authenticated-orcid":false,"given":"Jessica","family":"Flynn","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-2523","authenticated-orcid":false,"given":"Eric","family":"Davis","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Devlin","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2425-1069","authenticated-orcid":false,"given":"Andromachi","family":"Scaradavou","sequence":"additional","affiliation":[{"name":"3Pediatric Bone Marrow Transplant Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6308-9346","authenticated-orcid":false,"given":"Stephanie","family":"Chinapen","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Quach","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Cho","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-5053","authenticated-orcid":false,"given":"Sergio A.","family":"Giralt","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann A.","family":"Jakubowski","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-7880","authenticated-orcid":false,"given":"Richard J.","family":"Lin","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6066-1861","authenticated-orcid":false,"given":"Esperanza B.","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-4571","authenticated-orcid":false,"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9422-5766","authenticated-orcid":false,"given":"Doris","family":"Ponce","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Shaffer","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Tamari","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-6559","authenticated-orcid":false,"given":"James W.","family":"Young","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Politikos","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet N.","family":"Barker","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"4Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"12","key":"2024062115410591300_bib1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"key":"2024062115410591300_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"2024062115410591300_bib3","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1182\/bloodadvances.2020003371","article-title":"High progression-free survival after intermediate intensity double unit cord blood transplantation in adults","volume":"4","author":"Barker","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"2024062115410591300_bib4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/bmt.2016.217","article-title":"Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML","volume":"51","author":"Rashidi","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"2024062115410591300_bib5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National Marrow Donor Program\u2013sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide","volume":"39","author":"Shaw","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2024062115410591300_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2024062115410591300_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2019.11.017","article-title":"Evaluation of cord blood total nucleated and CD34+ cell content, cell dose, and 8-allele HLA match by patient ancestry","volume":"26","author":"Barker","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2024062115410591300_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2017.03.001","article-title":"Prospective evaluation of unrelated donor cord blood and haploidentical donor access reveals graft availability varies by patient ancestry: practical implications for donor selection","volume":"23","author":"Kosuri","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"2024062115410591300_bib9","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1182\/bloodadvances.2022007814","article-title":"Racial disparities in access to alternative donor allografts persist in the era of \u201cdonors for all\u201d","volume":"6","author":"Fingrut","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"2024062115410591300_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2024062115410591300_bib41","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/bloodadvances.2022008526","article-title":"Inaccuracies in assignment of patient race\/ethnicity: implications for unrelated donor searches and healthcare delivery","volume":"7","author":"Fingrut","year":"2023","journal-title":"Blood Adv"},{"issue":"15","key":"2024062115410591300_bib11","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2012-09-455063","article-title":"How I assess comorbidities before hematopoietic cell transplantation","volume":"121","author":"Sorror","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2024062115410591300_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"issue":"9213","key":"2024062115410591300_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(00)02137-1","article-title":"Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia","volume":"355","author":"Frassoni","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"2024062115410591300_bib14","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbmt.2020.09.013","article-title":"Barriers to hematopoietic cell transplantation for adults in the United States: a systematic review with a focus on age","volume":"26","author":"Flannelly","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2024062115410591300_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41409-018-0105-9","article-title":"Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: a national cancer database study","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2024062115410591300_bib16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","article-title":"Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2024062115410591300_bib17","first-page":"184.e1","article-title":"Likelihood of proceeding to allogeneic hematopoietic cell transplantation in the United States after search activation in the national registry: impact of patient age, disease, and search prognosis","volume":"27","author":"Dehn","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2024062115410591300_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bmt.2012.95","article-title":"Practice variation in physician referral for allogeneic hematopoietic cell transplantation","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2024062115410591300_bib19","doi-asserted-by":"crossref","first-page":"e0174760","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"2024062115410591300_bib20","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a center for International Blood and Marrow Transplant Research Analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024062115410591300_bib21","author":"Guzman","year":"2020"},{"issue":"2","key":"2024062115410591300_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/bmt.2012.54","article-title":"Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision","volume":"48","author":"Lown","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2024062115410591300_bib23","volume-title":"Tandem Meetings: Transplantation and Cellular Therapy Meetings of the ASTCT and CIBMTR","author":"Soln","year":"2022"},{"issue":"9","key":"2024062115410591300_bib24","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"key":"2024062115410591300_bib25","first-page":"525","article-title":"Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage","volume":"49","author":"Lown","year":"2014","journal-title":"BMT"},{"issue":"3","key":"2024062115410591300_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbmt.2019.10.012","article-title":"Role of race\/ethnicity in donor decisions about unrelated hematopoietic progenitor cell donation: exploring reasons for higher attrition among racial\/ethnic minorities","volume":"26","author":"Anthias","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2024062115410591300_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2002.v8.pm12064362","article-title":"Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow","volume":"8","author":"Barker","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024062115410591300_bib29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"2024062115410591300_bib30","volume-title":"Tandem Meetings: Transplantation and Cellular Therapy Meetings of the ASTCT and CIBMTR","author":"Politikos","year":"2022"},{"key":"2024062115410591300_bib28","author":"Phelan","year":"2020"},{"issue":"10","key":"2024062115410591300_bib31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/bloodadvances.2020001554","article-title":"Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant","volume":"4","author":"Sharma","year":"2020","journal-title":"Blood Adv"},{"key":"2024062115410591300_bib32","doi-asserted-by":"crossref","first-page":"100455","DOI":"10.1016\/j.eclinm.2020.100455","article-title":"The association of race and COVID-19 mortality","volume":"25","author":"Golestaneh","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2024062115410591300_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMp2012910","article-title":"Racial health disparities and Covid-19 - caution and context","volume":"383","author":"Chowkwanyun","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"2024062115410591300_bib34","unstructured":"National Marrow Donor Program\/Be The Match\n          . Cryopreservation Requirement in Effect Jan. 17 Due to COVID-19 Case Surge. 2022. Accessed 20 January 2022. https:\/\/network.bethematchclinical.org\/news\/nmdp\/be-the-match-response-to-covid-19\/updates-for-transplant-centers-and-cooperative-registries\/#TemporaryCryopreservation."},{"issue":"8","key":"2024062115410591300_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jtct.2021.05.014","article-title":"Attitudes about donating stem cells during COVID-19 among African American and Hispanic members of an unrelated donor registry","volume":"27","author":"Switzer","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"14","key":"2024062115410591300_bib35","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.2021012830","article-title":"Structural racism is a mediator of disparities in acute myeloid leukemia outcomes","volume":"139","author":"Abraham","year":"2022","journal-title":"Blood Adv"},{"key":"2024062115410591300_bib37","volume-title":"Tandem Meetings| Transplantation and Cellular Therapy Meetings of the ASTCT and CIBMTR","author":"Kota","year":"2022"},{"issue":"5","key":"2024062115410591300_bib38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bbmt.2017.12.791","article-title":"Validation of an algorithm to predict the likelihood of an 8\/8 Hla-matched unrelated donor at search initiation","volume":"24","author":"Davis","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2024062115410591300_bib39","doi-asserted-by":"crossref","first-page":"312.e1","DOI":"10.1016\/j.jtct.2023.02.016","article-title":"An optimized search prognosis tool to predict 8\/8 HLA-allele matched unrelated donor procurement","volume":"29","author":"Davis","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"2024062115410591300_bib40","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1200\/JOP.19.00133","article-title":"Rapid donor identification improves survival in high-risk first-remission patients with acute myeloid leukemia","volume":"16","author":"Pagel","year":"2020","journal-title":"JCO Oncology Practice"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3824\/2231145\/blooda_adv-2022-008572-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3824\/2231145\/blooda_adv-2022-008572-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T15:42:33Z","timestamp":1718984553000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/15\/3824\/486799\/Analysis-of-disparities-in-time-to-allogeneic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":41,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,8,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008572","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]}}}